USPSTF breast cancer screening guidelines are clear, concise; now let’s address gaps in quality

Scientific progress can’t help people if they can’t access care
This is a policy problem. And it is one we can change.

Scientific advances have produced therapies that allow some people with metastatic breast cancer to live longer and better. We want that progress to continue, and we will continue to fight for the right research necessary to achieve it.

September 18, 2026

Vol.52 No.34

By Frances M. Visco and Michelle Tregear

Cancer Policy

Kennedy overhauls “too woke” USPSTF with the appointment of eight members
Critics say new members will politicize, commercialize the panel

HHS Secretary Robert F. Kennedy, Jr., through the Agency for Healthcare Research and Quality, has announced the addition of eight new members to the U.S. Preventive Services Task Force.

September 18, 2026

Vol.52 No.34

By Claire Marie Porter

In Brief

Texas Oncology collaborates with ACS to promote cancer screening efforts across Texas

Texas Oncology is collaborating with the American Cancer Society to improve access to cancer screening and early detection in Texas through a new, exclusive statewide collaboration. The initiative focuses on breaking down barriers to screening, raising awareness about prevention, and helping more people catch cancer early.

September 18, 2026

Vol.52 No.34

Clinical Roundup

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds

Artificial intelligence may help radiologists identify subtle signs of breast cancers that are missed during routine mammograms—and some AI systems may even identify patterns associated with an increased risk of cancer before it becomes visible on a mammogram—but there are still many significant limitations, according to a review led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.

September 18, 2026

Vol.52 No.34

Clinical Roundup

Personalized weight-loss care benefits breast cancer survivors, JHU-led study finds

A personalized approach to obesity treatment may help breast cancer survivors improve their long-term health by identifying early which patients need more than behavioral lifestyle intervention alone, according to a Johns Hopkins Kimmel Cancer Center-led clinical trial.

September 18, 2026

Vol.52 No.34

Drugs & Targets

FDA approves imlunestrant + abemaciclib for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

FDA approved imlunestrant (Inluriyo) in combination with abemaciclib (Verzenio), for adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor 1 (ESR1)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.

September 18, 2026

Vol.52 No.34

USPSTF breast cancer screening guidelines are clear, concise; now let’s address gaps in quality

YOU MAY BE INTERESTED IN

Scientific progress can’t help people if they can’t access care
This is a policy problem. And it is one we can change.

Kennedy overhauls “too woke” USPSTF with the appointment of eight members
Critics say new members will politicize, commercialize the panel

Texas Oncology collaborates with ACS to promote cancer screening efforts across Texas

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds

Personalized weight-loss care benefits breast cancer survivors, JHU-led study finds

FDA approves imlunestrant + abemaciclib for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

Renew today!

Subscriber content

Never miss an issue!

Login

USPSTF breast cancer screening guidelines are clear, concise; now let’s address gaps in quality

YOU MAY BE INTERESTED IN

Scientific progress can’t help people if they can’t access careThis is a policy problem. And it is one we can change.

Kennedy overhauls “too woke” USPSTF with the appointment of eight membersCritics say new members will politicize, commercialize the panel

Texas Oncology collaborates with ACS to promote cancer screening efforts across Texas

AI may help identify breast cancers missed by mammograms, but clinical benefit remains uncertain, UCLA-led review finds

Personalized weight-loss care benefits breast cancer survivors, JHU-led study finds

FDA approves imlunestrant + abemaciclib for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

Never miss an issue!

Login

Scientific progress can’t help people if they can’t access care
This is a policy problem. And it is one we can change.

Kennedy overhauls “too woke” USPSTF with the appointment of eight members
Critics say new members will politicize, commercialize the panel